DRUG MONITOR, PANEL 1, SCREEN, URINE

The DRUG MONITOR, PANEL 1, SCREEN, URINE test contains 1 test with 13 biomarkers.

Drug Monitoring, Panel 1, Screen, Urine - The test is a screening assay using a homogeneous enzyme immunoassay method of analysis. Therapeutic urine drug monitoring is important for ensuring compliance to treatment strategies, as well as ensuring non-diversion for illicit purposes. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Urine drug test results equal to or greater than cutoff are reported as positive and results less than cutoff are reported as negative.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Amphetamines

Barbiturates

Benzodiazepines

Cocaine Metabolite

Creatinine

Marijuana Metabolite

Methadone

Opiates

Oxidant

Oxycodone

Ph

Phencyclidine

Specific Gravity

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.

Customer Reviews